Dual-label time-resolved immunofluorometric assay for simultaneous determination of pregnancy-associated plasma protein A and free β-subunit of human chorionic gonadotrophin

Journal of Immunological Methods

Volumn 205, Issue 2, 1997, Pages 169-175

  Qin, Qiuping ^a,b   Christiansen, Michael ^b   Lövgren, Timo ^a   Nørgaard Pedersen, Bent ^b   Pettersson, Kim ^a  

^a UNIVERSITY OF TURKU   (Finland)

^b Statens Seruminstitut ^*  (Denmark)

Author keywords

Down's syndrome; Free beta subunit of human chorionic gonadotrophin; Pregnancy associated plasma protein A; Screening; Time resolved fluorometry

Indexed keywords

CHORIONIC GONADOTROPIN BETA SUBUNIT; EUROPIUM; MONOCLONAL ANTIBODY; PREGNANCY ASSOCIATED PLASMA PROTEIN A; SAMARIUM;

ARTICLE; FEMALE; FLUOROMETRY; HUMAN; HUMAN TISSUE; IMMUNOASSAY; MATERNAL SERUM; PRIORITY JOURNAL; PROTEIN ANALYSIS;

ANTIBODIES, MONOCLONAL; BIOTIN; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; EVALUATION STUDIES; FEMALE; FLUOROIMMUNOASSAY; HUMANS; KINETICS; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS;

EID: 0030795580     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-1759(97)00073-2     Document Type: Article

References (14)

1. Casals, F., Fortuny, A., Grudzinskas, J.G., Suzuki, Y., Teisner, B., Comas, C., Sanllehy, C., Ojuel, J., Borrell, A., Soler, A., Ballesta, A.M., 1996. First-trimester biochemical screening for Down syndrome with the use of PAPP-A, AFP, and β-hCG. Prenat. Diagn. 16, 405.
2. Dickson, E.F., Pollak, A., Diamandis, E.P., 1995. Ultrasensitive bioanalytical assays using time-resolved fluorescence detection. Pharmacol. Ther. 66, 207.
3. Kricka, L.J., 1994. Selected strategies for improving sensitivity and reliability of immunoassays. Clin. Chem. 40, 347.
4. Lövgren, T., Pettersson, K., 1990. Time-resolved fluoroimmunoassay, advantages and limitations. In: Van Dyke, K., Van Dyke, R. (Eds.), Luminescence Immunoassay and Molecular Applications. CRC Press, Boca Raton, p. 233
5. Nørgaard-Pedersen, B., 1995. Towards acceptable practices for antenatal and neonatal screening for disease and disease risk. Clin. Genet. 46, 152.
6. Oxvig, C., Sand, O., Kristensen, T., Sottrup-Jensen, L., 1994. Isolation and characterization of circulating complex between human pregnancy-associated plasma protein-A and proform of eosinophil major basic protein. Biochim. Biophys. Acta 1201, 415.
7. Oxvig, C., Haaning, J., Kristensen, L., Wagner, J.M., Rubin, I., Stigbrand, T., Gleich, G.J., Sottrup-Jensen, L., 1995. Identification of angiotensinogen and complement C3dg as noval proteins binding proform of eosinophil major basic protein in human pregnancy serum and plasma. J. Biol. Chem. 270, 13645.
8. Pettersson, K., Alfthan, H., Stenman, U., Turpeinen, U., Suonpää, M., Söderholm, J., Larsen, S.O., Nørgaard-Pedersen, B., 1993. Simultaneous assay of α-fetoprotein and free β subunit of human chorionic gonadotrophin by dual-label time-resolved immunofluorometric assay. Clin. Chem. 39, 2084.
9. Qin, Q.P., Nguyen, T.H., Christiansen, M., Larsen, S.O., Norgaard-Pedersen, B., 1996. Time-resolved immunofluorometric assay of pregnancy-associated plasma protein A in maternal serum screening for Down's syndrome in maternal serum screening for Down's syndrome in first trimester of pregnancy. Clin. Chim. Acta 254, 113.
10. Qin, Q.P., Christiansen, M., Nguyen, T.H., Sorensen, S., Larsen, S.O., Norgaard-Pedersen, B., 1997. Schwangerschaftsprotein 1 (SP1) as maternal serum marker for Down's syndrome in first and second trimester. Prenat. Diagn. 17, 101.
11. Spencer, K., Aitken, D.A., Crossley, J.A., McCaw, G., Berry, E., Anderson, R., Connor, J.M., Macri, J.M., 1994. First trimester biochemical screening for trisomy 21: the role of free beta hCG, alpha fetoprotein and pregnancy associated plasma protein A. Ann. Clin. Biochem. 31, 447.
12. Wald, N.J., Densem, J.W., Smith, D., Klee, G.G., 1994. Four-marker serum screening for Down's syndrome. Prenat. Diagn. 14, 707.
13. Wald, N.J., Kennard, A., Hackshaw, A.K., 1995. First trimester serum screening for Down's syndrome. Prenat. Diagn. 15, 1227.
14. Wald, N.J., George, L., Smith, D., Densem, J.W., Pettersson, K., 1996. Serum screening for Down's syndrome between 8-14 weeks of pregnancy. Br. J. Obstet. Gynaecol. 103, 407.